Tag: WSC 2024
TASTE-2 results suggest ‘significant reduction’ in stroke-related disability with Sanbexin
Simcere Pharmaceutical Group has announced that a new study with major clinical findings regarding Sanbexin—an edaravone-dexborneol concentrated solution for injection—was recently presented at the...
Roughly half of all healthy life lost to stroke is caused...
The latest analysis of the Global Burden of Disease, Injuries and Risk Factors study (GBD), assessing data ranging from 1990–2021, has indicated that roughly...
